OtherNeuropharmacology
EFFECTS OF THE POTENTIAL ANTIDEPRESSANT OPC-14523 A COMBINED SIGMA AND 5-HT1A LIGAND: MODULATION OF NEURONAL ACTIVITY IN THE DORSAL RAPHE NUCLEUS
Jordanna E. Bermack, Nasser Haddjeri and Guy Debonnel
Journal of Pharmacology and Experimental Therapeutics March 24, 2004, DOI: https://doi.org/10.1124/jpet.104.066472
Jordanna E. Bermack
Nasser Haddjeri
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherNeuropharmacology
EFFECTS OF THE POTENTIAL ANTIDEPRESSANT OPC-14523 A COMBINED SIGMA AND 5-HT1A LIGAND: MODULATION OF NEURONAL ACTIVITY IN THE DORSAL RAPHE NUCLEUS
Jordanna E. Bermack, Nasser Haddjeri and Guy Debonnel
Journal of Pharmacology and Experimental Therapeutics March 24, 2004, DOI: https://doi.org/10.1124/jpet.104.066472
OtherNeuropharmacology
EFFECTS OF THE POTENTIAL ANTIDEPRESSANT OPC-14523 A COMBINED SIGMA AND 5-HT1A LIGAND: MODULATION OF NEURONAL ACTIVITY IN THE DORSAL RAPHE NUCLEUS
Jordanna E. Bermack, Nasser Haddjeri and Guy Debonnel
Journal of Pharmacology and Experimental Therapeutics March 24, 2004, DOI: https://doi.org/10.1124/jpet.104.066472
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement